Germany Skin Cancer Diagnostics Market Forecast 2023-2030

Germany Skin Cancer Diagnostics Market Forecast 2023-2030

KEY FINDINGS

The Germany skin cancer diagnostics market is estimated to accelerate with a 7.48% CAGR during the estimation period 2023-2030. The market growth is propelled by rising melanoma incidence, mandatory skin cancer screening, and substantial healthcare expenditure.

MARKET INSIGHTS

Data from the cancer registries of the Saarland and Schleswig-Holstein federal states in Germany underscore the rising incidence and mortality trends associated with skin cancer in the country. In 2019, malignant melanoma, a particularly aggressive skin tumor responsible for over 90% of skin cancer-related deaths, was diagnosed in approximately 22,411 individuals, with a roughly equal distribution between men and women.

Since 2008, Germany has instituted mandatory skin cancer screening by an extensive network of healthcare professionals, including dermatologists, general practitioners, and internists. Despite these efforts, the incidence of malignant melanoma has seen a consistent rise over recent decades, particularly in Bavaria. This trend may be attributed to increased life expectancy and a shift in recreational habits leading to heightened UV exposure.

The rising cost of developing new cancer drugs, with pre-launch R&D costs for anticancer drugs ranging from $944 million to $5.4 billion, significantly contributes to high drug acquisition costs. Given the increasing incidence of skin cancer, the established statutory skin cancer screening mechanism, and significant healthcare expenditure, the Germany skin cancer diagnostic market is poised for continued growth and evolution.

COMPETITIVE INSIGHTS

Leading market players operating cover NeraCare GmbH, AMLo Biosciences Ltd, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments